Recently, Lee et al. [16] found that LGALS3BP has antitumor activity in colorectal cancer (CRC) cells via suppression of Wnt signalling with a novel mechanism of ISGylation dependent ubiquitination of β-catenin. This evidence concerns the gene LGALS3BP and colorectal cancer.